Grant: Project Grant
University of Alberta
$1,032,750.00
Targeting Soluble Epoxide Hydrolase to Modulate Cardiomyocyte Senescence
FY 2025-26
Summary
As we age, our heart function gradually declines. Older adults often experience changes such as weaker heart pumping, stiffening of blood vessels, irregular heart rhythms, and a higher risk of heart disease. One reason for this decline is that the mitochondria in our heart cells become less efficient as we age. When mitochondria decline in function, they put stress on the cell and may set off harmful reactions that can further damage the heart. This harmful response can make the heart more vulnerable to events like a heart attack. Although heart
cells, known as cardiomyocytes, do not normally divide, they can still enter a state called "senescence" where they stop functioning properly and release harmful substances. This damaging process is partly controlled by a cellular alarm system known as the cGAS-STING pathway. Aging makes this worse by further damaging mitochondria, making the heart even more vulnerable to injury. Our previous research found that certain natural fat-based molecules, made by enzymes in the body, help protect mitochondria and reduce heart damage. But another enzyme, called soluble epoxide hydrolase (sEH), quickly breaks down
these protective molecules. We discovered that blocking or removing sEH in older animals helped protect the heart by keeping mitochondria healthier. In this project, we aim to explore how turning off sEH specifically in cardiomyocytes might prevent mitochondrial damage, slow down aging processes in the heart, and improve recovery after a heart attack in older individuals.
Department
Program
Project Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
563853
Name
Seubert John M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Cardiovascular System - B: Heart and Circulation
Projecttitle
Targeting Soluble Epoxide Hydrolase to Modulate Cardiomyocyte Senescence
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$1,032,750
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Aging; Cardiomyocyte; Heart; Mitochondria; Senescence; Soluble Epoxide Hydrolase
Abstract
As we age, our heart function gradually declines. Older adults often experience changes such as weaker heart pumping, stiffening of blood vessels, irregular heart rhythms, and a higher risk of heart disease. One reason for this decline is that the mitochondria in our heart cells become less efficient as we age. When mitochondria decline in function, they put stress on the cell and may set off harmful reactions that can further damage the heart. This harmful response can make the heart more vulnerable to events like a heart attack. Although heart
cells, known as cardiomyocytes, do not normally divide, they can still enter a state called "senescence" where they stop functioning properly and release harmful substances. This damaging process is partly controlled by a cellular alarm system known as the cGAS-STING pathway. Aging makes this worse by further damaging mitochondria, making the heart even more vulnerable to injury. Our previous research found that certain natural fat-based molecules, made by enzymes in the body, help protect mitochondria and reduce heart damage. But another enzyme, called soluble epoxide hydrolase (sEH), quickly breaks down
these protective molecules. We discovered that blocking or removing sEH in older animals helped protect the heart by keeping mitochondria healthier. In this project, we aim to explore how turning off sEH specifically in cardiomyocytes might prevent mitochondrial damage, slow down aging processes in the heart, and improve recovery after a heart attack in older individuals.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Seubert, John M
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,032,750~ $0~